NCT03574415

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean

A Single-center, Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of DWP14012 in Healthy Japanese, Caucasian and Korean

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: All
• Age: 19 Years – 50 Years
• Healthy volunteers: Accepted

Summary

To evaluate the safety and tolerability of single and multiple ascending oral doses of DWP14012 in healthy Japanese, Caucasian and Korean subjects

Conditions

• Healthy Volunteers

Interventions

Type	Name	Description
DRUG	DWP14012	DWP14012 tablets
DRUG	Placebo	DWP14012 placebo-matching tablets

Timeline

• Start date: 2018-11-01
• Primary completion: 2019-01-18
• Completion: 2019-01-23
• First posted: 2018-07-02
• Last updated: 2019-06-27

Locations

1 site across 1 country: South Korea